TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 120, Issue 5, Pages 555-564
Publisher
Springer Nature
Online
2019-02-15
DOI
10.1038/s41416-019-0397-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
- (2018) Mélanie Mahe et al. EMBO Molecular Medicine
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy
- (2017) Yemsratch T. Akalu et al. IMMUNOLOGICAL REVIEWS
- Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
- (2017) Canan Kasikara et al. MOLECULAR CANCER RESEARCH
- Molecular insights of Gas6/TAM in cancer development and therapy
- (2017) Guiling Wu et al. Cell Death & Disease
- Rationale for anti-CD137 cancer immunotherapy
- (2016) Amani Makkouk et al. EUROPEAN JOURNAL OF CANCER
- Targeting TYRO3 inhibits epithelial–mesenchymal transition and increases drug sensitivity in colon cancer
- (2016) C-W Chien et al. ONCOGENE
- TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
- (2016) Robin Schmitz et al. Oncotarget
- Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
- (2016) Xun Chen et al. Journal of Cancer
- The Receptor Tyrosine Kinase AXL in Cancer Progression
- (2016) Erinn Rankin et al. Cancers
- The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies
- (2015) Julie Earl et al. BMC GENOMICS
- Emerging therapeutic targets in bladder cancer
- (2015) Benedito A. Carneiro et al. CANCER TREATMENT REVIEWS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Targeting Signaling Transduction Pathways in Bladder Cancer
- (2015) Phillip H. Abbosh et al. Current Oncology Reports
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
- (2014) Weihe Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
- (2014) S. Rebouissou et al. Science Translational Medicine
- Independent Component Analysis Uncovers the Landscape of the Bladder Tumor Transcriptome and Reveals Insights into Luminal and Basal Subtypes
- (2014) Anne Biton et al. Cell Reports
- Evaluation of Tyro3 Expression, Gas6-Mediated Akt Phosphorylation, and the Impact of Anti-Tyro3 Antibodies in Melanoma Cell Lines
- (2013) Stephen J. Demarest et al. BIOCHEMISTRY
- PI3K/AKT pathway activation in bladder carcinogenesis
- (2013) Julien Calderaro et al. INTERNATIONAL JOURNAL OF CANCER
- Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
- (2013) W Leconet et al. ONCOGENE
- Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas
- (2013) Hiba el Sayadi et al. Targeted Oncology
- Biology of the TAM Receptors
- (2013) G. Lemke Cold Spring Harbor Perspectives in Biology
- Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
- (2011) E. Avilla et al. CANCER RESEARCH
- Discovery ofN-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily
- (2009) Gretchen M. Schroeder et al. JOURNAL OF MEDICINAL CHEMISTRY
- A genomic screen identifies TYRO3 as a MITF regulator in melanoma
- (2009) S. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More